Fluorescent magnetic submicronic polymer (FMSP) nanoparticles induce cell death in human colorectal carcinoma cells
Source abstract
Abstract
Nanoparticles have many advantages such as high biocompatibility, bioavailability and effective therapeutic capabilities. The aim of the present study is to examine whether fluorescent magnetic submicronic polymer nanoparticles (FMSP-nanoparticles) have any impact on human colorectal cancer cells. In the present study, we have tested FMSP-nanoparticles with an average size of 100-200 nm on human colorectal carcinoma cells (HCT-116) to check their cytotoxic and anti-cancer capabilities. The effects of FMSP-nanoparticles on cancer cells were observed after 6 h, 24 h and 48 h intervals. The response of FMSP-nanoparticles-treated cells was evaluated by Trypan Blue, 4lue-diamidino-2-phenylindole (DAPI) and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays. Our MTT analysis results revealed that FMSP-nanoparticles produced dose-dependent effects on cancer cells, FMSP-nanoparticles with dose of 1.25 µg/mL did not decrease cell survivability, whereas dosages of 12.5 µg/mL and 50 µg/mL respectively showed 23.59% and 59.47% decrease in the cancer cell survivability. In conclusion, our results demonstrate FMSP-nanoparticles have a potential anti-cancer capability and hold a great promise for colon cancer treatments.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Nanoparticles: synthesis and applications · Graphene and Nanomaterials Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Stem Cell Biology, Institute for Research and Medical Consultations, Imam Abdulrahman Bin Faisal University
Department of Biophysics, Institute for Research and Medical Consultations, Imam Abdulrahman Bin Faisal University
University of Lyon
LAGEP-CPE, University Lyon 1, Villeurbanne, CNRS, UMR 5007
Funding
Deanship of Scientific Research, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia
References (50)
Show source-provided references
1. National Cancer Institute at National Institutes of Health (NIH). Cancer stat facts: ovarian cancer 2016. Available from: https://seer.cancer.gov/statfacts/html/ovary.html
2. 10.3322/caac.2120810.3322/caac.21208 ↗
3. American Association for Cancer Research (AACR) Cancer Progress Report. 2017. Available from: https://www.aacrfoundation.org/Pages/cancer-progress-report.aspx
4. 10.2174/13895570677636140210.2174/138955706776361402 ↗
5. Yaffee P, Osipov A, Tan C, et al. Review of systemic therapies for locally advanced and metastatic rectal cancer. J Gastrointest Oncol. 2015;6:185–200.
6. 10.1016/j.ijpharm.2018.02.00710.1016/j.ijpharm.2018.02.007 ↗
7. 10.1007/s10585-007-9135-110.1007/s10585-007-9135-1 ↗
8. 10.1080/10937404.2011.61511310.1080/10937404.2011.615113 ↗
9. 10.1038/sj.cdd.440123110.1038/sj.cdd.4401231 ↗
10. 10.1139/o05-11610.1139/o05-116 ↗
11. 10.1080/0022293070131493210.1080/00222930701314932 ↗
12. 10.1088/0957-4484/19/29/29510310.1088/0957-4484/19/29/295103 ↗
13. 10.1016/j.ccr.2008.06.00410.1016/j.ccr.2008.06.004 ↗
14. 10.1016/j.envpol.2008.11.00410.1016/j.envpol.2008.11.004 ↗
15. 10.1517/17425247.2010.50256010.1517/17425247.2010.502560 ↗
16. 10.1016/j.gde.2010.12.00810.1016/j.gde.2010.12.008 ↗
17. 10.1016/j.bbadis.2013.10.01510.1016/j.bbadis.2013.10.015 ↗
18. 10.1093/toxsci/kfw01010.1093/toxsci/kfw010 ↗
19. 10.1007/s11095-017-2302-410.1007/s11095-017-2302-4 ↗
20. 10.1081/DMR-12002649710.1081/DMR-120026497 ↗
21. 10.1016/j.jcis.2014.03.01110.1016/j.jcis.2014.03.011 ↗
22. 10.1366/12-0696310.1366/12-06963 ↗
23. 10.1039/c0ib00132e10.1039/c0ib00132e ↗
24. 10.1016/j.jcis.2009.11.05910.1016/j.jcis.2009.11.059 ↗
25. 10.1016/S0006-3495(02)75567-710.1016/S0006-3495(02)75567-7 ↗
26. 10.1002/anie.20171252810.1002/anie.201712528 ↗
27. 10.1007/s00396-005-1334-110.1007/s00396-005-1334-1 ↗
28. 10.2147/IJN.S5188010.2147/IJN.S51880 ↗
29. Barar J, Omidi Y. Surface modified multifunctional nanomedicines for simultaneous imaging and therapy of cancer. Bioimpacts. 2014;4:3–14.
30. Heidari MM, Barar J, Asgari D, et al. Targeted fluoromagnetic nanoparticles for imaging of breast cancer mcf-7 cells. Adv Pharm Bull. 2013;3:189–195.
31. 10.1186/1477-3155-10-210.1186/1477-3155-10-2 ↗
32. Omidi Y. Smart multifunctional theranostics: simultaneous diagnosis and therapy of cancer. Bioimpacts. 2011;1:145–147.
33. 10.1002/jps.2235110.1002/jps.22351 ↗
34. Sudeep HV, Gouthamchandra K, Venkatesh BJ, et al. Viwithan, a standardized Withania somnifera root extract induces apoptosis in murine melanoma cells. Pharmacogn Mag. 2018;13:S801–S806.
35. 10.1016/j.foodchem.2017.09.08610.1016/j.foodchem.2017.09.086 ↗
36. 10.1016/j.bbrc.2017.10.04410.1016/j.bbrc.2017.10.044 ↗
37. 10.1016/j.jep.2017.08.01110.1016/j.jep.2017.08.011 ↗
38. 10.1016/S1875-5364(17)30076-610.1016/S1875-5364(17)30076-6 ↗
39. 10.1186/s11658-017-0041-510.1186/s11658-017-0041-5 ↗
40. 10.1016/j.biopha.2017.05.10810.1016/j.biopha.2017.05.108 ↗
41. 10.18632/oncotarget.2256310.18632/oncotarget.22563 ↗
42. 10.3892/etm.2017.407910.3892/etm.2017.4079 ↗
43. 10.1080/21691401.2018.147052610.1080/21691401.2018.1470526 ↗
44. 10.1080/21691401.2017.137365510.1080/21691401.2017.1373655 ↗
45. 10.15171/apb.2016.04810.15171/apb.2016.048 ↗
46. 10.2147/IJN.S10369510.2147/IJN.S103695 ↗
47. 10.2217/nnm.14.110.2217/nnm.14.1 ↗
48. 10.1021/mp300223210.1021/mp3002232 ↗
49. 10.2147/PGPM.S5837410.2147/PGPM.S58374 ↗
50. 10.1016/j.ijpharm.2013.03.03210.1016/j.ijpharm.2013.03.032 ↗